Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vanessa D. Costa"'
Autor:
Francisco C. A. Mello, Tairine M. Barros, Giovana P. Angelice, Vanessa D. Costa, Vinicius M. Mello, Maria Inês M. C. Pardini, Elisabeth Lampe, Barbara V. Lago, Livia M. Villar
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Hepatitis D virus (HDV) is classified into 8 genotypes (1 to 8) and several subgenotypes. In Brazil, HDV-3 and HDV-1 predominate; however, most of the diagnosis efforts and molecular studies are directed to the area of endemicity of the Amaz
Externí odkaz:
https://doaj.org/article/637713d893514cae84ff5999be8b674a
Autor:
Vanessa D. Costa, Patricia Pellegrini, Vivian Rotman, Ana Maria Pittella, Estevão P. Nunes, Barbara V. Lago, Elisabeth Lampe, Francisco C. A. Mello
Publikováno v:
Viruses, Vol 11, Iss 11, p 1004 (2019)
In Brazil, hepatitis C treatment has been evolving significantly with the licensing of direct-acting antivirals (DAAs). However, viral determinants (amino acid substitutions in hepatitis C virus (HCV) genome and infective genotype) associated with ho
Externí odkaz:
https://doaj.org/article/6c0c3fe159814d72a4952875537f16c8
Autor:
Barbara V. Lago, Marcia P. do Espirito-Santo, Vanessa D. Costa, Vanessa A. Marques, Livia M. Villar, Lia L. Lewis-Ximenez, Elisabeth Lampe, Francisco C. A. Mello
Publikováno v:
Viruses, Vol 11, Iss 9, p 860 (2019)
Hepatitis B virus (HBV) subgenotypes may be related to clinical outcomes and response to antiviral therapy. Most Brazilian studies on HBV subgenotypes are restricted to some regions and to specific population groups. Here, we provide an insight about
Externí odkaz:
https://doaj.org/article/eae315cab7644ec99cb3c0693ebc75ba
Autor:
Vanessa D Costa, Carlos E Brandão-Mello, Estevão P Nunes, Pedro Guilherme Corôa Dos Santos Silva, Lia Laura Lewis Ximenez de Souza Rodrigues, Elisabeth Lampe, Francisco Campello do Amaral Mello
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216327 (2019)
The selection of viral strains with resistance-associated substitutions at hepatitis C virus (HCV) NS5A and NS5B genes is considered one of the limiting factors for achieving sustained virologic response (SVR) to combination of direct-acting antivira
Externí odkaz:
https://doaj.org/article/64c32fabef904e8f8762cf1f34d5275c